Condition
Cornea Ectasia
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
33.3%-53% vs avg
Key Insights
Highlights
Success Rate
33% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
Termination Rate
50.0%
2 terminated out of 4 trials
Success Rate
33.3%
-53.2% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results33% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Terminated2
Completed1
Recruiting1
Trial Success Rate
33.3%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT03095235Not ApplicableTerminated
Dietary Riboflavin (Vitamin B-2) and Cornea Cross-Linking
NCT03030755RecruitingPrimary
Corneal Elastography and Patient Specific Modeling
NCT04240457Phase 2Terminated
Safety and Efficacy of Corneal Crosslinking Using the PXL-Platinum 330 for Eyes With Corneal Ectatic Conditions
NCT06498570Not ApplicableCompletedPrimary
Clinical Outcomes of Two Symmetrical Kera-rings Implantation in Grade Three Keratoconus
Showing all 4 trials